These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4007030)

  • 1. Mechanism of warfarin potentiation by amiodarone: dose--and concentration--dependent inhibition of warfarin elimination.
    Almog S; Shafran N; Halkin H; Weiss P; Farfel Z; Martinowitz U; Bank H
    Eur J Clin Pharmacol; 1985; 28(3):257-61. PubMed ID: 4007030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potentiation of warfarin anticoagulation by amiodarone.
    Hamer A; Peter T; Mandel WJ; Scheinman MM; Weiss D
    Circulation; 1982 May; 65(5):1025-9. PubMed ID: 7074739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of desethylamiodarone in the anticoagulant effect of concurrent amiodarone and warfarin therapy.
    Naganuma M; Shiga T; Nishikata K; Tsuchiya T; Kasanuki H; Fujii E
    J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):363-7. PubMed ID: 11907638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone reduces plasma warfarin clearance in man.
    Watt AH; Stephens MR; Buss DC; Routledge PA
    Br J Clin Pharmacol; 1985 Dec; 20(6):707-9. PubMed ID: 4092002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans.
    O'Reilly RA; Trager WF; Rettie AE; Goulart DA
    Clin Pharmacol Ther; 1987 Sep; 42(3):290-4. PubMed ID: 3621782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between warfarin sodium and amiodarone.
    Martinowitz U; Rabinovich J; Goldfarb D; Many A; Bank H
    N Engl J Med; 1981 Mar; 304(11):671-2. PubMed ID: 7453749
    [No Abstract]   [Full Text] [Related]  

  • 7. Prospective study of the potentiation of acenocoumarol by amiodarone.
    Richard C; Riou B; Berdeaux A; Fournier C; Khayat D; Rimailho A; Giudicelli JF; Auzépy P
    Eur J Clin Pharmacol; 1985; 28(6):625-9. PubMed ID: 4065185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence, magnitude, and time course of the amiodarone-warfarin interaction.
    Kerin NZ; Blevins RD; Goldman L; Faitel K; Rubenfire M
    Arch Intern Med; 1988 Aug; 148(8):1779-81. PubMed ID: 3401099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of co-treatment with carbamazepine, amiodarone and statins on warfarin metabolism and maintenance dose.
    Herman D; Locatelli I; Grabnar I; Peternel P; Stegnar M; Lainscak M; Mrhar A; Breskvar K; Dolzan V
    Eur J Clin Pharmacol; 2006 Apr; 62(4):291-6. PubMed ID: 16552506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of amiodarone.
    Latini R; Tognoni G; Kates RE
    Clin Pharmacokinet; 1984; 9(2):136-56. PubMed ID: 6370540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism of the interaction between amiodarone and warfarin in humans.
    Heimark LD; Wienkers L; Kunze K; Gibaldi M; Eddy AC; Trager WF; O'Reilly RA; Goulart DA
    Clin Pharmacol Ther; 1992 Apr; 51(4):398-407. PubMed ID: 1563209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potentiation of acenocoumarol anticoagulant effect by amiodarone.
    Arboix M; Frati ME; Laporte JR
    Br J Clin Pharmacol; 1984 Sep; 18(3):355-60. PubMed ID: 6487475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of the amiodarone-warfarin interaction during long-term follow-up.
    Lu Y; Won KA; Nelson BJ; Qi D; Rausch DJ; Asinger RW
    Am J Health Syst Pharm; 2008 May; 65(10):947-52. PubMed ID: 18463344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiodarone-digoxin interaction: clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implications.
    Nademanee K; Kannan R; Hendrickson J; Ookhtens M; Kay I; Singh BN
    J Am Coll Cardiol; 1984 Jul; 4(1):111-6. PubMed ID: 6736437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical observations with the amiodarone/warfarin interaction: dosing relationships with long-term therapy.
    Sanoski CA; Bauman JL
    Chest; 2002 Jan; 121(1):19-23. PubMed ID: 11796427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Digoxin-amiodarone interaction].
    Strocchi E; Malini PL; Graziani A; Ambrosioni E; Magnani B
    G Ital Cardiol; 1984 Jan; 14(1):12-5. PubMed ID: 6706051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of warfarin at steady state.
    Routledge PA; Chapman PH; Davies DM; Rawlins MD
    Br J Clin Pharmacol; 1979 Sep; 8(3):243-7. PubMed ID: 497091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of amiodarone on oral digoxin bioavailability in healthy volunteers.
    Maragno I; Santostasi G; Gaion RM; Paleari C
    Int J Clin Pharmacol Res; 1984; 4(2):149-53. PubMed ID: 6469441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.
    Holford NH
    Clin Pharmacokinet; 1986; 11(6):483-504. PubMed ID: 3542339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of amiodarone on serum quinidine and procainamide levels.
    Saal AK; Werner JA; Greene HL; Sears GK; Graham EL
    Am J Cardiol; 1984 May; 53(9):1264-7. PubMed ID: 6711425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.